Trial Profile
A prospective, multicenter, Open-label, non-comparative study of fixed-dose olmesartan/amlodipine for the treatment of hypertension in Korean patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Oct 2016
Price :
$35
*
At a glance
- Drugs Olmesartan medoxomil/amlodipine (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms ACE-HY
- 20 Oct 2016 New trial record